Android app on Google Play

Somaxon Pharmaceuticals (SOMX) Posts Q4 Loss of 21c/Share, Inline with the Street

March 8, 2012 4:24 PM EST Send to a Friend
Get Alerts SOMX Hot Sheet
Trade SOMX Now!
Join SI Premium – FREE
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q4 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.42 million.

Lowered its FY12 total non-GAAP operating expenses to $15-$16 million.

For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment